David Shaw
HELP

David Shaw’s Helus Pharma Inc. Common Stock HELP Stock Holding History

David Shaw’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Buy
+61,782
New +$309K ﹤0.01% 4275

Other funds holding HELP

VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Sphera Funds Management
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Nan Fung Group Holdings
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

David Shaw's HELP Position: Q2 2026 in Review

David Shaw opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 61,782 shares worth $408K. The stake represents ﹤0.01% of the portfolio and ranks #4275 among its holdings.

99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • David Shaw held 61,782 shares of Helus Pharma Inc. Common Stock worth $408K as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new David Shaw position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4275 holding.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.